GB1358001A - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- GB1358001A GB1358001A GB1928372A GB1928372A GB1358001A GB 1358001 A GB1358001 A GB 1358001A GB 1928372 A GB1928372 A GB 1928372A GB 1928372 A GB1928372 A GB 1928372A GB 1358001 A GB1358001 A GB 1358001A
- Authority
- GB
- United Kingdom
- Prior art keywords
- methaqualone
- april
- pharmaceutical compositions
- drug
- complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
1358001 Methaqualone-resin complex SASUCO SA 26 April 1972 [26 April 1971] 19283/ 72 Heading A5B [Also in Division C3] The invention comprises methaqualone bound to a copolymer of methacrylic acid and divinylbenzene. The resin preferably has a particle size of 0.5-500Á and about 4% of cross- linkages. In this form the drug is readily released for absorption in the stomach. The drug complex may be combined with a carrier and put up into any conventionel pharmaceutical form.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LU63060 | 1971-04-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1358001A true GB1358001A (en) | 1974-06-26 |
Family
ID=19726690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1928372A Expired GB1358001A (en) | 1971-04-26 | 1972-04-26 | Pharmaceutical compositions |
Country Status (6)
Country | Link |
---|---|
CH (1) | CH540695A (en) |
DE (1) | DE2220504A1 (en) |
FR (1) | FR2134503B1 (en) |
GB (1) | GB1358001A (en) |
LU (1) | LU63060A1 (en) |
NL (1) | NL7205573A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993007860A1 (en) | 1991-10-24 | 1993-04-29 | Kabi Pharmacia Ab | New drug formulations with ion-exchangers |
US8062667B2 (en) | 2006-03-16 | 2011-11-22 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
US8999386B2 (en) | 2012-08-15 | 2015-04-07 | Tris Pharma, Inc. | Methylphenidate extended release chewable tablet |
US11590081B1 (en) | 2017-09-24 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine tablets |
US11590228B1 (en) | 2015-09-08 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine compositions |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2355829A1 (en) * | 1999-01-07 | 2000-07-13 | Louise Templeton | Multiparticulate oral dosage forms |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR7017E (en) * | ||||
BE560809A (en) * |
-
1971
- 1971-04-26 LU LU63060D patent/LU63060A1/xx unknown
-
1972
- 1972-04-21 CH CH598872A patent/CH540695A/en not_active IP Right Cessation
- 1972-04-25 NL NL7205573A patent/NL7205573A/xx unknown
- 1972-04-25 FR FR7214686A patent/FR2134503B1/fr not_active Expired
- 1972-04-26 GB GB1928372A patent/GB1358001A/en not_active Expired
- 1972-04-26 DE DE2220504A patent/DE2220504A1/en active Pending
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993007860A1 (en) | 1991-10-24 | 1993-04-29 | Kabi Pharmacia Ab | New drug formulations with ion-exchangers |
US5643560A (en) * | 1991-10-24 | 1997-07-01 | Pharmacia & Upjohn Ab | Drug formulation with ion-exchangers |
US9549989B2 (en) | 2006-03-16 | 2017-01-24 | Tris Pharma, Inc | Modified release formulations containing drug-ion exchange resin complexes |
US10668163B2 (en) | 2006-03-16 | 2020-06-02 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
US9675704B2 (en) | 2006-03-16 | 2017-06-13 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
US8491935B2 (en) | 2006-03-16 | 2013-07-23 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
US8597684B2 (en) | 2006-03-16 | 2013-12-03 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
US8747902B2 (en) | 2006-03-16 | 2014-06-10 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
US8790700B2 (en) | 2006-03-16 | 2014-07-29 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
US8883217B2 (en) | 2006-03-16 | 2014-11-11 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
US8062667B2 (en) | 2006-03-16 | 2011-11-22 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
US10933143B2 (en) | 2006-03-16 | 2021-03-02 | Tris Pharma, Inc | Modified release formulations containing drug-ion exchange resin complexes |
US9198864B2 (en) | 2006-03-16 | 2015-12-01 | Tris Pharma, Inc | Modified release formulations containing drug-ion exchange resin complexes |
US8202537B2 (en) | 2006-03-16 | 2012-06-19 | Tris Pharma Inc | Modified release formulations containing drug-ion exchange resin complexes |
US9522191B2 (en) | 2006-03-16 | 2016-12-20 | Tris Pharma, Inc. | Modified release formulations containing drug—ion exchange resin complexes |
US10172958B2 (en) | 2006-03-16 | 2019-01-08 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
US10086087B2 (en) | 2006-03-16 | 2018-10-02 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
US8337890B2 (en) | 2006-03-16 | 2012-12-25 | Tris Pharma Inc | Modified release formulations containing drug-ion exchange resin complexes |
US9675703B2 (en) | 2006-03-16 | 2017-06-13 | Tris Pharma, Inc | Modified release formulations containing drug - ion exchange resin complexes |
US9295642B2 (en) | 2012-08-15 | 2016-03-29 | Tris Pharma, Inc. | Methylphenidate extended release chewable tablet |
US9844545B2 (en) | 2012-08-15 | 2017-12-19 | Tris Pharma, Inc. | Methylphenidate extended release chewable tablet |
US11633389B2 (en) | 2012-08-15 | 2023-04-25 | Tris Pharma, Inc | Methylphenidate extended release chewable tablet |
US9545399B2 (en) | 2012-08-15 | 2017-01-17 | Tris Pharma, Inc. | Methylphenidate extended release chewable tablet |
US10507203B2 (en) | 2012-08-15 | 2019-12-17 | Tris Pharma, Inc | Methylphenidate extended release chewable tablet |
US9844544B2 (en) | 2012-08-15 | 2017-12-19 | Tris Pharma, Inc | Methylphenidate extended release chewable tablet |
US10857143B2 (en) | 2012-08-15 | 2020-12-08 | Tris Pharma, Inc | Methylphenidate extended release chewable tablet |
US11103494B2 (en) | 2012-08-15 | 2021-08-31 | Tris Pharma, Inc | Methylphenidate extended release chewable tablet |
US11103495B2 (en) | 2012-08-15 | 2021-08-31 | Tris Pharma, Inc | Methylphenidate extended release chewable tablet |
US9180100B2 (en) | 2012-08-15 | 2015-11-10 | Tris Pharma, Inc. | Methylphenidate extended release chewable tablet |
US8999386B2 (en) | 2012-08-15 | 2015-04-07 | Tris Pharma, Inc. | Methylphenidate extended release chewable tablet |
US11590228B1 (en) | 2015-09-08 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine compositions |
US11590081B1 (en) | 2017-09-24 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine tablets |
Also Published As
Publication number | Publication date |
---|---|
FR2134503B1 (en) | 1976-07-02 |
DE2220504A1 (en) | 1973-02-15 |
FR2134503A1 (en) | 1972-12-08 |
CH540695A (en) | 1973-08-31 |
NL7205573A (en) | 1972-10-30 |
LU63060A1 (en) | 1971-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1330878A (en) | Ketamine resolution | |
FI865227A (en) | FOERFARANDE FOER FRAMSTAELLNING AV ETT DEPOT-PREPARAT. | |
IL38571A (en) | 5-pyrrolidone-(2)-carboxylic acid esters and their manufacture | |
GB1358001A (en) | Pharmaceutical compositions | |
IL35564A0 (en) | Esters of substituted anthranilic acid,their preparation and pharmaceutical compositions containing them | |
IL40685A0 (en) | Pharmaceutical compositions for the dissolution of renal calculi and their preparation | |
IL37013A0 (en) | Basically substituted alkylidene-aminooxyalkyl carboxylic acid esters,their preparation and pharmaceutical compositions containing them | |
GB1402691A (en) | Composition of 4-biphenyl acetic acid | |
IL40110A (en) | 1-imidazolyl-methanephosphonic acid esters,their production and pharmaceutical compositions containing them | |
GB1311015A (en) | Pharmaceutical compositions and a process for the manufacture thereof | |
GB1321419A (en) | Pharmaceutical composition | |
IL33937A0 (en) | O-chloroalkyl-and o-bromoalkyl-s-benzyl-s'-alkyl-dithiophosphoric acid esters,their preparation and their use as pesticides | |
GB1254057A (en) | Improvements in or relating to therapeutical composition containing vincamine | |
IL33731A0 (en) | O,o-dialkyl-s-(1,2,2-trichloroethyl)-thionothiolphosphoric acid esters and o-alkyl-s-(1,2,2-trichloroethyl)-alkanethionothiolphosphonic acid esters,their preparation and use as insecticides | |
GB1294538A (en) | Pharmaceutical compositions | |
BE758838A (en) | HETEROCYLIC CARBOXYLIC ACID ESTERS AND MEDICINAL PRODUCTS CONTAINING SUCH SUBSTANCES | |
GB1191554A (en) | New Analgesic Composition. | |
IE34730L (en) | Indomethacin suppositories | |
GB1417817A (en) | Substituted acetic acid cyclohexyl esters the preparation thereof and pharmaceutical compositions containing them | |
ES390407A1 (en) | Pharmaceutical tablet | |
CA967700A (en) | In situ process for trans-isomerization and conjugation of resins containing fatty acid esters | |
CA996572A (en) | Process for the preparation of acrylate and methacrylate esters | |
CA953508A (en) | Production of smooth and spheroidal ferrosilicon particles | |
IL39565A0 (en) | The preparation of acid amides and pharmaceutical compositions containing them | |
Fazio | QUANTITATIVE PSYCHOPHARMACOLOGY AND CLINICAL PROBLEMS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PLNP | Patent lapsed through nonpayment of renewal fees |